Skip to main content

Month: January 2024

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024 Paris, France, January 17, 2024 – 5:00 pm (CET) – Pixium Vision SA (Euronext Growth Paris – FR001400JX97; Mnemo: ALPIX), a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces that the Paris Commercial Court has postponed its decision on the takeover offer filed on November 20, 2023 and the opening of judicial liquidation proceedings to January 31, 2024. The Company will apply to Euronext Paris for its shares to be suspended from that date. Pixium draws investors’ attention to the fact that, given the price offered by the prospective buyer and the Company’s level of indebtedness, the sale proceeds...

Continue reading

EF Hutton Will Host Annual Global Conference on May 15, 2024 in New York City

NEW YORK, NY, Jan. 17, 2024 (GLOBE NEWSWIRE) — via NewMediaWire –  EF Hutton, an investment bank headquartered in New York, today announced that the registration window is open for its Annual Global Conference taking place on May 15, 2024, at the Plaza Hotel in New York City, showcasing dynamic public and private companies across multiple sectors in an intimate setting. The EF Hutton Annual Global Conference features key executives from public and private companies conveying their unique stories to an extensive audience including institutional investors, high-net worth individuals, corporate clients, and exclusive members of the press. Investors and executives will have the opportunity to interact with each other in a friendly, high-energy environment. The conference has a one-on-one format, with no general presentations. “Our...

Continue reading

CTS Corporation to Participate in the Needham Growth Conference

LISLE, Ill., Jan. 17, 2024 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) announced today that Kieran O’Sullivan, President and Chief Executive Officer, will be participating at the 26th Annual Needham Growth Conference on January 17, 2024, at 3:45 PM (EDT). You may access a live webcast of the event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com. The webcast will also be available for replay on this website for 90 days following the presentation. About CTS CTS Corporation (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For...

Continue reading

Toll Brothers Announces New Phase Now Open at Walsh Master-Planned Community in Fort Worth, Texas

Toll Brothers at WalshToll Brothers newest phase and a new line of luxury home designs now open within the Walsh master-planned community in Fort Worth, Texas.FORT WORTH, Texas, Jan. 17, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest phase and a new line of luxury home designs is now open for sale within the Walsh master-planned community in Fort Worth, Texas. Toll Brothers at Walsh is located at 13756 Parkline Way in Fort Worth. The Sales Center is now open and the brand-new professionally decorated model home is under construction and expected to open in spring 2024. Toll Brothers has been building luxury homes in the Walsh master plan since 2017. The company’s newest section, Toll Brothers at Walsh, features thoughtfully designed floor...

Continue reading

Signing Day Sports President Richard Symington Interviewed on “The Big Biz Show”

SCOTTSDALE, AZ, Jan. 17, 2024 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, today announced that Richard Symington, President of Signing Day Sports, participated in an interview with “The Big Biz Show,” an Emmy Award-winning, nationally syndicated, TV and radio show. During the interview, Mr. Symington discussed the benefits for student-athletes utilizing the Signing Day Sports app to get all of the information that schools are looking for in one place, allowing them to own their recruiting journey. The interview aired on cable TV and streaming services, including Roku, as well as on radio via The Biz Talk Radio Network, Armed Forces Radio, and iHeart Media...

Continue reading

CISO Global to Present at the 26th Annual Needham Growth Conference

SCOTTSDALE, Ariz., Jan. 17, 2024 (GLOBE NEWSWIRE) — CISO Global (NASDAQCM: CISO), an industry leader as a managed cybersecurity and compliance provider, announced today that David Jemmett, Chief Executive Officer, will present virtually at the 26th Annual Needham Growth Conference. The conference is being held at the Lotte New York Palace Hotel in New York City from January 16-19, 2024. Event: 26th Annual Needham Growth Conference Presentation Date: Friday, January 19, 2024 Time: 12:45 pm ET Jemmett will be available for one-on-one meetings on Friday. Please contact a Needham representative to schedule. To register for the conference, click here. NOTE: The CISO Global presentation will be available following the conference for attendees at https://wsw.meetmax.com/webcast/needham134/ciso/?ukey=6fe114e04404c0b0d6698611363325e0 About...

Continue reading

Intravenous Immunoglobulin Market Size Worth USD 24.76 Billion in 2032 | Emergen Research

Increasing prevalence of immunodeficiency disease, rising adoption of Intravenous immunoglobulin treatment and rapid technological advancement in therapy are key factors driving Intravenous Immunoglobulin (IVIG) market revenue growth Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) — The global Intravenous Immunoglobulin (IVIG) market size was USD 12.10 Billion in 2022 and is expected to register a revenue CAGR of 7.5% during the forecast period. Increasing prevalence of immunodeficiency disease, rising adoption of Intravenous immunoglobulin treatment and rapid technological advancement in therapy are key factors driving market revenue growth. In addition, growing investment in healthcare industry is contributing significantly to the market growth. The intravenous immunoglobulin market has grown rapidly, driven by the goal of treating...

Continue reading

Aerospace Fasteners Market to Surpass 8.24 Billion by 2030 Drives Due to Increasing Air Traffic across the World

SkyQuest projects that the aerospace fasteners market will attain a value of USD 8.24 billion by 2030, with a CAGR of 7.7% over the forecast period (2023-2030). The aerospace fasteners market is experiencing robust growth globally, fueled by several key factors. One of the primary drivers is the increasing air traffic worldwide, as more people choose air travel as their preferred mode of transportation. Westford, USA, Jan. 17, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the growth trajectory of the global aerospace fasteners market is intricately linked with the expanding production of commercial and military aircraft worldwide. This surge in aircraft manufacturing is a direct response to the ever-increasing demand for air travel and the ongoing efforts of aerospace companies to modernize their fleets. Browse in-depth TOC on...

Continue reading

Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Update

Management Releases Corporate Roadmap of Revenues and AcquisitionsRodedawg International Industries Inc. RoadmapRodedawg International Industries Inc. RoadmapCOSTA MESA, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — Rodedawg International Industries, Inc. (OTC: RWGI) proudly announces the company has released the Company Roadmap of key corporate activities and revenue expectations. Chris Swartz, CEO, states “We are proud to inform our shareholders of our vision for 2024 and beyond since the completion of the acquisition of Parabola Mgmt., LLC. Given that the acquisition included ownership of the California licensed cannabis company with options to purchase additional licenses, we will be moving quickly to expanding the revenues of the Company via our central sales hub for distribution in southern California. Soon, we have...

Continue reading

Lung Cancer Market Size Worth USD 88.4 Billion in 2032 | Emergen Research

Rising demand for minimally invasive procedure and technological advancements in Lung cancer treatment are key factors driving Lung Cancer market revenue growth. Vancouver, Jan. 17, 2024 (GLOBE NEWSWIRE) — The global lung cancer market size was USD 29.8 Billion in 2022 and is expected to register a rapid revenue CAGR of 11.6% during the forecast period. Rising demand for minimally invasive procedure and technological advancements in Lung cancer treatment are key factors driving market revenue growth. Prevalence of lung cancer is rising as focus on preventing and treating cancer using the body’s own immune system is increasing. Most common types of lung cancer are small cell lung cancer and NSCLC. The most significant advancement in lung cancer market over the past year is the development of immunotherapy, which uses the body’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.